Public Company News

ASX listed PharmAust’s wholly owned subsidiary Epichem has posted a record monthly revenue result for January. Pharmaust is developing a promising anti-cancer drug known as “Monepantel” at the Perth based Epichem facility that also undertakes contract work for some of the worlds leading pharmaceutical companies 

Australia has a new Lithium producer and WA’s Lithium boom is well and truly underway. Neometal’s giant Mt Marion mine near Coolgardie, this week joined the ranks of Lithium producers as the first shipment of concentrates sailed for delivery to Chinese partner Ganfeng Lithium. Ganfeng will take 100% of the project concentrates for the next three years.

Lithium Australia say they would have one of the world’s largest Lithium development and exploration portfolio’s under one roof if shareholders of fellow ASX listed Lithium player Lepidico accept their audacious takeover bid launched today. It would also bring together two Lithium processing technologies under one roof and end the costly IP legal battle between the parties. 

Mobile banking and payments company Peppermint Innovation will lever off their burgeoning Philippines mobile payments business to create a new international money remittance business in Australia this year. It will make good use of Peppermint's entrenched position within the Philippines banking market to provide money transfers between the two countries. 

Australia could soon have its first heavy rare earths mine after Northern Minerals said they were rapidly approaching a final investment decision at the Browns Range project in northern WA. The Perth-based company took some big strides with the project in the past quarter, including the appointment of Sinosteel MECC as EPC contractor.

If the extraordinary revenue growth of Perth based, ASX listed CV Check is any guide, employers are clearly becoming more and more suspicious of dodgy CV’s being submitted by job seekers. Employers appear to be embracing the concept of stress testing a job candidate's CV after CV Check posted a 50% jump in quarterly revenues for the December quarter.

Blackham Resources looks set to add another revenue stream at Wiluna by striking a deal with ASX-listed GWR Group to mine their neighboring West Wiluna gold deposits on a profit share arrangement. The West Wiluna gold project, just 40kms from Blackham’s newly recommissioned Wiluna gold plant, contains an estimated gold resource of more than 250,000 ounces.

Troy Resources have developed some exciting new exploration targets near their Karouni gold mine in Guyana, South America, including a new prospect measuring 1200m by 150m. The new targets stem from a major review of historical geophysical data that may have generated some breakthrough ideas for targeting gold in the Karouni mine area.

ASX listed PharmAust has received a $400,000 rebate from the Federal Government in recognition of their cutting edge research and development program being undertaken at two of the Perth-based company’s wholly owned subsidiaries.  Pharmaust’s new anti-cancer drug, Monepantel, has been powering though human and K9 trials with considerable success. 

Lithium Australia’s exciting Lake Johnston project is looking good after a geophysical survey identified multiple new targets that could represent Lithium-bearing pegmatites lurking just below surface. Lake Johnston, 420km east of Perth, shot to prominence with the nearby discovery of the sizeable Earl Grey Lithium deposit.

Sipa Resources have kicked off their 2017 exploration programs in both Uganda and the Paterson region in the north of W.A. The company is a little different to many other exploration hopefuls in so much as both of their projects appear to boast huge mineralized systems and if they can find the source of the mineralization they may well have at least one and maybe two tier 1 projects. 

ASX-listed MGC Pharmaceuticals march towards full commercialisation of its cannabis-based dermatological skin care line is a step closer with the company announcing the start of human clinical trials of its products. The company says it plans to commence sales of its unique derma skin care range that will target acne amongst other things from September.